of her employment, the patient began to complain of intense headaches, asthenia, irritability and upper respiratory tract irritation that she associated with the use of the solvent. For this reason, she spontaneously decided to leave her job, and found employment in a clothes shop, where she had no contact with chemical agents. She continued to suffer headaches.
Two weeks after leaving the shoe shop, the patient lost consciousness at home and was admitted to the Emergency Department (ED) of the local hospital. She presented with involuntary myoclonic-type movements in all four limbs and left-sided weakness. The physical examination was normal except for anomalous movements in all four limbs, predominantly on the left side. The blood count and blood biochemistry were normal. Brain computed tomography (CT), magnetic resonance imaging (MRI), electroencephalogram (EEG), electromyography (EMG) and somatosensory evoked potentials were within normal limits. Cerebral perfusion, SPECT (Single Photon Emission Computed Tomography) and psychometric studies were also normal. Administration of clonazepam 3 mg daily allowed partial control of the myoclonic movement and the patient was discharged after five days.
In the following six weeks, the patient continued to suffer from almost constant headaches, moderate asthenia and weakness in the left limbs, although the myoclonic movements had greatly improved. A cerebral PET (Positron Emission Tomography) scan (Fig. 1 ) during follow-up detected a reduction in global cerebral metabolic activity and a deficit of focal metabolism in the right subthalamus with mild thalamic asymmetry. At the cortical level, there was reduced metabolism in the right hemisphere. There were no deficits or asymmetries in the basal ganglia. A further neurophysiologic study showed electromyographic activity compatible with spontaneous and action myoclonias and normal corticospinal conduction.
One month later, the patient was admitted to the ED due to increasingly intense headaches, confusion, speech difficulties and unstable gait. The neurological examination showed positive Romberg's sign, myoclonic movements in the left arm and poor coordination in the left leg. The fundus oculi examination was normal. The confusion remitted spontaneously. Additional tests excluded prion encephalopathy, Creutzfeldt-Jakob disease and myoclonus epilepsy associated with ragged-red fibres. A further neurological examination showed a static, dynamic ataxia that prevented the patient walking without help. Further EEG, brain MRI, blink reflex, auditory, visual, and somatosensory evoked potential tests were normal.
Treatment with sodium valproate was started and the headaches, myoclonus and dynamic ataxia improved, allowing the patient to walk with help. Neuropsychological tests showed cognitive deterioration with a deficit of hand-eye coordination and associative memory.
Two years after the diagnosis of myoclonic encephalopathy secondary to occupational exposure to TEC, the patient continues to suffer from continuous headaches, asthenia, motor difficulties and unstable gait. The involuntary movements are well-controlled by treatment with sodium valproate, clonazepam and a muscle relaxant.
Discussion
Myoclonic encephalopathy has been reported in a series of toxic conditions due to bismuth, methyl bromide, manganese, lead, mercury, colloidal silver, rodenticides containing alpha-chloralose, drugs such as dopa, lamotrigine, carisoprodol, cefuroxime and lithium, and mushroom ingestion. Myoclonic encephalopathy has been reported in various other conditions, such as anoxic encephalopathy following cardiac arrest, head trauma, stroke, tumors, and degenerative or metabolic (especially uremia) central nervous system diseases 2) .
TEC may cause damage to both the central and peripheral nervous system. It is a highly volatile, liposoluble solvent that may cause central nervous system depression with great affinity for the cranial nerves, most frequently the trigeminal, optic and facial nerves and, exceptionally, other cranial nerves, leading to polyneuropathy, cerebellar tremor and extrapyramidal deficits. Cases of central vestibular involvement have also been described. Reported sequelae of acute poisoning include headaches, amnesia, psychosis, limb weakness and hemiparesis [3] [4] [5] . Chronic exposure may lead to diffuse cerebral damage which manifests as headaches, asthenia, anorexia, vertigo, severe memory loss, depression, emotional disorders and, in more serious cases, clinical manifestations compatible with dementia 6) .
Asymmetrical neurological involvement means that in some case the symptoms are compatible with multiple sclerosis. TEC potentiates the hepatotoxic effect of ethanol and may cause an anti-abuse effect when alcohol is ingested before during or after exposure. TEC is a human cancerigen 7) . Damage to other systems may include contact dermatitis and skin burns 8) , disorders of the cardiac rhythm and pulmonary, hepatic and renal alterations 9) .
The use of TEC, even sporadically, in badly-ventilated spaces without personal protection can lead to severe 10, 11) or even fatal intoxication 12) . In spite of its high level of toxicity, TEC is widely used and easily available in Spain and Europe for use as a stain remover, solvent and grease remover. According to data from the ECSA (European Chlorinate Solvent Association www.eurochlor.org), more than 52,000 tons of TEC were used in Europe in 2002.
Values of free trichloroethanol in blood (biological limit: 4 mg/l), trichloroacetic acid in urine (biological limit: 100 mg/g creatinine) and trichloroacetic acid + trichloroethanol in urine (biological limit: 300 mg/g creatinine) should be determined to aid diagnosis of the poisoning and biological control of exposed workers. In the case presented here, no toxicological analysis was available because the elimination half-life of TEC is very short and the patient did not go to the hospital until a relatively long time after the exposure. Neither were environmental analyses of TEC in the workplace available, as the exposure did not occur on strictly industrial premises but rather in a small shop which used TEC sporadically as a solvent and was not subject to obligatory environmental monitoring.
This case emphasizes a possible unusual neurological presentation of occupational exposure to TEC.
